公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2018 | Cerebellar α 6 -subunit-containing GABA A receptors: a novel therapeutic target for disrupted prepulse inhibition in neuropsychiatric disorders | LIH-CHU CHIOU ; Lee H.-J.; Ernst M.; Huang W.-J.; Chou J.-F.; Chen H.-L.; Mouri A.; Chen L.-C.; Treven M.; Mamiya T.; PI-CHUAN FAN ; Knutson D.E.; Witzigmann C.; Cook J.; Sieghart W.; Nabeshima T. | British Journal of Pharmacology | 23 | 21 | |
2018 | Design and Synthesis of Novel Deuterated Ligands Functionally Selective for the γ-Aminobutyric Acid Type A Receptor (GABA A R) α6 Subtype with Improved Metabolic Stability and Enhanced Bioavailability | Knutson D.E.; Kodali R.; Divovi? B.; Treven M.; Stephen M.R.; Zahn N.M.; Dobri?i? V.; Huber A.T.; Meirelles M.A.; Verma R.S.; Wimmer L.; Witzigmann C.; Arnold L.A.; LIH-CHU CHIOU ; Ernst M.; Mihovilovic M.D.; Savi? M.M.; Sieghart W.; Cook J.M. | Journal of Medicinal Chemistry | 33 | 29 | |
2022 | Targeting α6GABAA receptors as a novel therapy for schizophrenia: A proof-of-concept preclinical study using various animal models | Lee M.T.; Mouri A.; Kubota H.; Lee H.-J.; Chang M.-H.; Wu C.-Y.; Knutson D.E.; Mihovilovic M.; Cook J.; Sieghart W.; Nabeshima T.; LIH-CHU CHIOU | Biomedicine and Pharmacotherapy | 7 | 4 | |
2018 | The α6 subunit-containing GABA A receptor: A novel drug target for inhibition of trigeminal activation | PI-CHUAN FAN ; Lai T.-H.; Hor C.C.; Lee M.T.; Huang P.; Sieghart W.; Ernst M.; Knutson D.E.; Cook J.; LIH-CHU CHIOU | Neuropharmacology | 16 | 15 | |
2022 | α6-Containing GABAA Receptors: Functional Roles and Therapeutic Potentials | Sieghart W.; LIH-CHU CHIOU ; Ernst M.; Fabjan J.; Savić M.M.; Lee M.T. | Pharmacological Reviews | 13 | 12 | |
2021 | α6GABAA Receptor Positive Modulators Alleviate Migraine-like Grimaces in Mice via Compensating GABAergic Deficits in Trigeminal Ganglia | Tzeng H.-R.; Lee M.T.; PI-CHUAN FAN ; Knutson D.E.; Lai T.-H.; Sieghart W.; Cook J.; LIH-CHU CHIOU | Neurotherapeutics | 14 | 10 |